Full text
Earnings transcript
Read the complete earnings call transcript.
PG
The Procter & Gamble Company
$145.77
-1.2
(-0.82%)
| Exchange: | NYSE |
| Market Cap: | 346.526B |
| Shares Outstanding: | 2.657B |
Delayed data
About The Company
| Sector: | Consumer Defensive | |||||
| Industry: | Household & Personal Products | |||||
| CEO: | Shailesh G. Jejurikar | |||||
| Full Time Employees: | 109000 | |||||
| Address: |
| |||||
| Website: | http://us.pg.com |
The Procter & Gamble Company, commonly referred to as P&G, is a global enterprise that supplies a broad spectrum of branded consumer products to markets worldwide. The company’s operations are divided into five main business divisions: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers an assortment of hair care products, including conditioners, shampoos, styling aids, and treatments, under popular names like Head & Shoulders, Herbal Essences, Pantene, and Rejoice. It also features antiperspirants, deodorants, personal cleansing solutions, and skin care items from brands such as Olay, Old Spice, Safeguard, Secret, and SK-II. Within the Grooming division, P&G provides a range of shave care products and grooming appliances, prominently featuring brands like Braun, Gillette, and Venus. The Health Care unit encompasses oral hygiene essentials, including toothbrushes, toothpastes, and other dental care products sold under the Crest and Oral-B brand names. This segment further extends to gastrointestinal remedies, rapid diagnostics, respiratory care, vitamins/minerals/supplements, pain relief, and various other personal health care items from brands such as Metamucil, Neurobion, Pepto-Bismol, and Vicks. In the Fabric & Home Care category, consumers find fabric enhancers, laundry additives, and laundry detergents through labels like Ariel, Downy, Gain, and Tide. Additionally, this division offers air care products, dishwashing solutions, professional cleaning supplies (P&G Professional), and surface cleaners, exemplified by brands such as Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer. Finally, the Baby, Feminine & Family Care segment provides infant care products, including baby wipes, taped diapers, and pants, under the Luvs and Pampers brands. It also supplies adult incontinence and feminine hygiene products from Always, Always Discreet, and Tampax, along with paper towels, tissues, and toilet paper marketed as Bounty, Charmin, and Puffs. P&G distributes its extensive product portfolio through a vast commercial network, including large retail chains, e-commerce platforms, grocery stores, membership clubs, pharmacies, department stores, various distributors, wholesalers, specialty beauty retailers, high-frequency stores, electronics outlets, and professional channels, as well as direct-to-consumer sales. The Procter & Gamble Company was established in 1837 and its corporate headquarters are located in Cincinnati, Ohio.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 84,039,000 | 84,284,000 | 87,032,000 |
| Gross Profit | 43,191,000 | 43,120,000 | 43,669,000 |
| EBITDA | 22,582,000 | 23,921,000 | 21,254,000 |
| Operating Income | 18,545,000 | 20,451,000 | 19,748,000 |
| Net Income | 14,879,000 | 15,974,000 | 16,046,000 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Total Assets | 122,370,000 | 125,231,000 | 126,521,000 |
| Total Liabilities | 71,812,000 | 72,946,000 | 72,210,000 |
| Total Stockholders Equity | 50,286,000 | 52,284,000 | 54,311,000 |
| Total Debt | 33,369,000 | 34,508,000 | 34,138,000 |
| Cash and Cash Equivalents | 9,482,000 | 9,556,000 | 9,942,000 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Operating Cash Flow | 19,846,000 | 17,817,000 | 20,322,000 |
| Capital Expenditure | -3,322,000 | -3,773,000 | -4,409,000 |
| Free Cash Flow | 16,524,000 | 14,044,000 | 15,913,000 |
| Net Income | 14,879,000 | 16,065,000 | 16,144,000 |
| Net Change in Cash | 1,236,000 | 74,000 | 412,000 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2031 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 92,706,734.036 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 96,247,391.804 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 94,163,000 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 24,606,327.698 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 25,546,093.145 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 24,992,851.481 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 16,094,339.031 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 16,897,203.981 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 16,424,550.006 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 24,673,036.741 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 25,615,349.940 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 25,060,608.410 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 6.780 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 6.980 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 6.640 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 5 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 2 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates PG intrinsic value between $98.36 – $151.16 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about PG valuation
Is The Procter & Gamble Company (PG) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for The Procter & Gamble Company (PG) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is PG a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether PG trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is PG’s P/E ratio?
You can see PG’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for PG?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is PG a good long-term investment?
Whether PG fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
PG
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-0.82
Trading Metrics:
| Open: | 144.9 | Previous Close: | 146.97 | |
| Day Low: | 143.88 | Day High: | 145.81 | |
| Year Low: | 137.62 | Year High: | 167.25 | |
| Price Avg 50: | 147.38 | Price Avg 200: | 148.03 | |
| Volume: | 6M | Average Volume: | 8.853M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freePG full analysis
Hey everyone, welcome back to the channel. Today we are putting one of the most iconic names in consumer goods under the microscope: The Procter & Gamble Company, ticker PG. This is a comprehensive deep dive where we’ll cover everything from the business model and earnings to the financials, a full SWOT analysis, and our intrinsic value calculation. By the end, you’ll know exactly where I stand on this stock. Let’s get into it. Now, P&G is a staple in…
